NCT00062933View on ClinicalTrials.gov

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

September 30, 2007

Study Completion Date

March 31, 2008

Conditions
Melanoma
Interventions
PROCEDURE

Laparotomy

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00062933 - A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma | Biotech Hunter | Biotech Hunter